AAAAAA

   
Results: 1-15 |
Results: 15
MIYOSHI-MYOPATHY IN SAUDI-ARABIA - CLINICAL, ELECTROPHYSIOLOGICAL, HISTOPATHOLOGICAL AND RADIOLOGICAL FEATURES
Authors: CUPLER EJ BOHLEGA S HESSLER R MCLEAN D STIGSBY B AHMAD J
Citation: Ej. Cupler et al., MIYOSHI-MYOPATHY IN SAUDI-ARABIA - CLINICAL, ELECTROPHYSIOLOGICAL, HISTOPATHOLOGICAL AND RADIOLOGICAL FEATURES, Neuromuscular disorders, 8(5), 1998, pp. 321-326
CONGENITAL ACETYLCHOLINE-RECEPTOR DEFICIENCY WITH CONCURRENT ABSENCE OF ACETYLCHOLINE ESTERASE
Authors: CUPLER EJ HESSLER R DABBAGH O BOHLEGHA S STIGSBY B
Citation: Ej. Cupler et al., CONGENITAL ACETYLCHOLINE-RECEPTOR DEFICIENCY WITH CONCURRENT ABSENCE OF ACETYLCHOLINE ESTERASE, Neurology, 50(4), 1998, pp. 1017-1017
NEUROPATHIES IN HIV-INFECTION
Authors: DALAKAS MC CUPLER EJ
Citation: Mc. Dalakas et Ej. Cupler, NEUROPATHIES IN HIV-INFECTION, Bailliere's clinical neurology, 5(1), 1996, pp. 199-218
ACETYLCHOLINE-RECEPTOR ANTIBODIES AS A MARKER OF TREATABLE FATIGUE INHIV-1-INFECTED INDIVIDUALS
Authors: CUPLER EJ OTERO C HENCH K LUCIANO C DALAKAS MC
Citation: Ej. Cupler et al., ACETYLCHOLINE-RECEPTOR ANTIBODIES AS A MARKER OF TREATABLE FATIGUE INHIV-1-INFECTED INDIVIDUALS, Muscle & nerve, 19(9), 1996, pp. 1186-1188
INCLUSION-BODY MYOSITIS IN HIV-1 AND HTLV-1 INFECTED PATIENTS
Authors: CUPLER EJ LEONMONZON M MILLER J SEMINOMORA C ANDERSON TL DALAKAS MC
Citation: Ej. Cupler et al., INCLUSION-BODY MYOSITIS IN HIV-1 AND HTLV-1 INFECTED PATIENTS, Brain, 119, 1996, pp. 1887-1893
ELECTROPHYSIOLOGICAL AND PATHOLOGICAL-CHANGES IN 2',3'-DIDEOXYCYTIDINE-INDUCED NEUROPATHY IN AN ANIMAL-MODEL
Authors: RUSSELL JW CUPLER EJ DALAKAS MC
Citation: Jw. Russell et al., ELECTROPHYSIOLOGICAL AND PATHOLOGICAL-CHANGES IN 2',3'-DIDEOXYCYTIDINE-INDUCED NEUROPATHY IN AN ANIMAL-MODEL, Annals of neurology, 38(2), 1995, pp. 306-306
EXACERBATION OF PERIPHERAL NEUROPATHY BY LAMIVUDINE
Authors: CUPLER EJ DALAKAS MC
Citation: Ej. Cupler et Mc. Dalakas, EXACERBATION OF PERIPHERAL NEUROPATHY BY LAMIVUDINE, Lancet, 345(8947), 1995, pp. 460-461
THE EFFICACY OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM)
Authors: DALAKAS MC DAMBROSIA JM SEKUL EA CUPLER EJ SIVAKUMAR K
Citation: Mc. Dalakas et al., THE EFFICACY OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM), Neurology, 45(4), 1995, pp. 208-208
INCLUSION-BODY MYOSITIS (IBM) IN HIV-INFECTED AND HTLV-I-INFECTED PATIENTS
Authors: CUPLER EJ LEONMONZON M MILLER J ANDERSON T DALAKAS MC
Citation: Ej. Cupler et al., INCLUSION-BODY MYOSITIS (IBM) IN HIV-INFECTED AND HTLV-I-INFECTED PATIENTS, Neurology, 45(4), 1995, pp. 209-209
EARLY FEATURES OF ZIDOVUDINE-ASSOCIATED MYOPATHY - HISTOPATHOLOGICAL FINDINGS AND CLINICAL CORRELATIONS
Authors: CUPLER EJ DANON MJ JAY C HENCH K ROPKA M DALAKAS MC
Citation: Ej. Cupler et al., EARLY FEATURES OF ZIDOVUDINE-ASSOCIATED MYOPATHY - HISTOPATHOLOGICAL FINDINGS AND CLINICAL CORRELATIONS, Acta Neuropathologica, 90(1), 1995, pp. 1-6
THE NATURAL-HISTORY OF ZIDOVUDINE (AZT)-INDUCED MITOCHONDRIAL MYOPATHY (ZIMM)
Authors: CUPLER EJ HENCH K JAY CA GRADY C DANON MJ ROPKA M DALAKAS MC
Citation: Ej. Cupler et al., THE NATURAL-HISTORY OF ZIDOVUDINE (AZT)-INDUCED MITOCHONDRIAL MYOPATHY (ZIMM), Neurology, 44(4), 1994, pp. 10000132-10000132
EFFECT OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN ON AMYOTROPHIC-LATERAL-SCLEROSIS AND MULTIFOCAL MOTOR NEUROPATHY
Authors: DALAKAS MC STEIN DP OTERO C SEKUL E CUPLER EJ MCCROSKY S
Citation: Mc. Dalakas et al., EFFECT OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN ON AMYOTROPHIC-LATERAL-SCLEROSIS AND MULTIFOCAL MOTOR NEUROPATHY, Archives of neurology, 51(9), 1994, pp. 861-864
ASEPTIC-MENINGITIS ASSOCIATED WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY - FREQUENCY AND RISK-FACTORS
Authors: SEKUL EA CUPLER EJ DALAKAS MC
Citation: Ea. Sekul et al., ASEPTIC-MENINGITIS ASSOCIATED WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY - FREQUENCY AND RISK-FACTORS, Annals of internal medicine, 121(4), 1994, pp. 259-262
INTRAVENOUS IMMUNOGLOBULIN (IVIG)-ASSOCIATED MENINGITIS (AM) - FREQUENCY AND RISK-FACTORS IN TREATMENT OF PATIENTS WITH NEUROMUSCULAR DISEASE
Authors: SEKUL EA SOUEIDAN SA CUPLER EJ DALAKAS MC
Citation: Ea. Sekul et al., INTRAVENOUS IMMUNOGLOBULIN (IVIG)-ASSOCIATED MENINGITIS (AM) - FREQUENCY AND RISK-FACTORS IN TREATMENT OF PATIENTS WITH NEUROMUSCULAR DISEASE, Neurology, 43(4), 1993, pp. 203-203
THE EARLY HISTOLOGICAL ABNORMALITIES OF SUBCLINICAL AZT-MYOPATHY (AZT-MY)
Authors: CUPLER EJ DANON MJ JAY CA ROPKA M HENCH K DALAKAS MC
Citation: Ej. Cupler et al., THE EARLY HISTOLOGICAL ABNORMALITIES OF SUBCLINICAL AZT-MYOPATHY (AZT-MY), Neurology, 43(4), 1993, pp. 374-374
Risultati: 1-15 |